학술논문
Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: A phase 3 randomised double-blind placebo-controlled trial
Document Type
Article
Author
O'Brien, K.L.; Chandran, A.; Weatherholtz, R.; Millar, E.V.; Reid, R.; Moulton, L.H.; Karron, R.A.; Santosham, M.; Donaldson, C.; Eick-Cost, A.; Perilla, M.; Campbell, J.; VanDeReit, D.; Brown, L.B.; Gloyd, P.W.; Seby, M.; Jafri, H.S.; Griffin, M.P.; Bellamy, T.; Jensen, K.M.; Harris, B.S.; Losonsky, G.A.; Brown, M.A.; Candelaria, D.; Foti, J.L.; Overturf, G.
Source
In: The Lancet Infectious Diseases . (The Lancet Infectious Diseases, 1 December 2015, 15(12):1398-1408)
Subject
Language
English
ISSN
14744457
14733099
14733099